| Analysis | Metabolite Name | Measured Value | Units | Genotype | TREATMENT | TIME_POINT |
|---|---|---|---|---|---|---|
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.354762371 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.486031986 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.563765967 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.612512663 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.630116995 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.644906117 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.654681312 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.661784326 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.693248048 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.705764556 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.765054791 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.796658965 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.798315494 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.798949415 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.835424266 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.846986878 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.870823859 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.913284195 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.931670673 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 0.977871295 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.022128705 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.038288242 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.061831481 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.110885069 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.116316648 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.315848932 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.387749737 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.452465179 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.456141993 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.659832003 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.783177985 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 1.789861802 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 2.157174468 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 2.584396119 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 2.603295056 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 2.820934809 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 4.622054812 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 4.824105699 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 5.609145999 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | N-stearoyl-sphingosine (d18:1/18:0)* | 5.717158265 | Normalized AUC | SCAP KO | LPS | 48hr |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|